Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of the intestinal tract in the elimination of uric acid.

Literature DB >> 5859543

Role of the intestinal tract in the elimination of uric acid.

L B Sorensen.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1965 PMID： 5859543 DOI： 10.1002/art.1780080429

Source DB: PubMed Journal: Arthritis Rheum ISSN： 0004-3591

Keyword Cloud
Cited

× No keyword cloud information.

47 in total

1. Predicting allopurinol response in patients with gout.

Authors: Daniel F B Wright; Stephen B Duffull; Tony R Merriman; Nicola Dalbeth; Murray L Barclay; Lisa K Stamp
Journal: Br J Clin Pharmacol Date: 2015-12-29 Impact factor: 4.335

2. Uricosuric agents in uremic sera. Identification of indoxyl sulfata and hippuric acid.

Authors: E F Boumendil-Podevin; R A Podevin; G Richet
Journal: J Clin Invest Date: 1975-06 Impact factor: 14.808

3. Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors.

Authors: Lenka Hasikova; Marketa Pavlikova; Hana Hulejova; Petr Kozlik; Kveta Kalikova; Aparna Mahajan; Martin Herrmann; Blanka Stiburkova; Jakub Zavada
Journal: Rheumatol Int Date: 2019-07-31 Impact factor: 2.631

4. Nephrolithiasis in inflammatory bowel disease.

Authors: E A Gelzayd; R I Breuer; J B Kirsner
Journal: Am J Dig Dis Date: 1968-12

5. Experimental observations and mathematical considerations on the mechanism of transport of uric acid across human gastric mucosa.

Authors: D P Mertz
Journal: Pflugers Arch Date: 1970 Impact factor: 3.657

Role of the intestinal tract in the elimination of uric acid.

1. Predicting allopurinol response in patients with gout.

2. Uricosuric agents in uremic sera. Identification of indoxyl sulfata and hippuric acid.

3. Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors.

4. Nephrolithiasis in inflammatory bowel disease.

5. Experimental observations and mathematical considerations on the mechanism of transport of uric acid across human gastric mucosa.

6. Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.

7. Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010.

Review 8. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Review 9. Gut microbiome in chronic kidney disease: challenges and opportunities.

10. Low serum uric acid level is a risk factor for death in incident hemodialysis patients.